BFM
LONA

Boothbay Fund Management’s LeonaBio Inc LONA Stock Holding History

Boothbay Fund Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,840
Closed -$178K – 2235
2022
Q2 		$178K Buy
5,840
+3,390
+138% +$311K ﹤0.01% 1797
2022
Q1 		$331K Buy
+2,450
New +$258K 0.01% 1550

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boothbay Fund Management's LONA Position: Q3 2022 in Review

Boothbay Fund Management sold out of LeonaBio Inc (LONA) in Q3 2022, closing a stake of 3,390 shares — an estimated $103K sold.

Boothbay Fund Management first reported a position in LONA in Q2 2022 and held it in 1 quarter. The position peaked at $103K in Q2 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q3 2022.

  • Boothbay Fund Management reported no remaining LeonaBio Inc position as of Q3 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 3,390 LeonaBio Inc shares in Q3 2022, an estimated $103K.
  • Boothbay Fund Management first reported a position in LeonaBio Inc in Q2 2022 and held it in 1 quarter.
  • Boothbay Fund Management's LeonaBio Inc position peaked at $103K in Q2 2022.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2022.

Based on Boothbay Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.